Jonathan Weiss / Shutterstock
Eli Lillys The Phase III SURPASS 2 clinical trial shows treatment with tirzepatide, a once-weekly dual glucose-dependent insulinotropic polypeptide and glucagon-like...
Peptron said Friday the company will unveil its new diabetes treatment, which works continuously for a month, at the American Diabetes Association (ADA) conference...